Evidence map›Paper›PMID 37477604›Full record

ArticleThe journal of physical chemistry. B2023

Binding of a Pyrene-Based Fluorescent Amyloid Ligand to Transthyretin: A Combined Crystallographic and Molecular Dynamics Study.

Nghia Nguyen Thi Minh, Afshan Begum, Jun Zhang, Petter Leira, Yogesh Todarwal, Mathieu Linares, Patrick Norman, Dean Derbyshire, Eleonore von Castelmur, Mikael Lindgren and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The journal of physical chemistry. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Nghia Nguyen Thi MinhInstitute of Physical Chemistry and Electrochemistry, Leibniz University Hannover, Callinstr. 3A, 30167 Hannover, Germany.
Afshan BegumDivision of Chemistry Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden.
Jun ZhangDivision of Chemistry Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden.
Petter LeiraDepartment of Physics, Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Yogesh TodarwalDepartment of Theoretical Chemistry and Biology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, SE-106 91 Stockholm, Sweden.
Mathieu LinaresDepartment of Theoretical Chemistry and Biology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, SE-106 91 Stockholm, Sweden.ORCID 0000-0002-9720-5429
Patrick NormanDepartment of Theoretical Chemistry and Biology, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, SE-106 91 Stockholm, Sweden.ORCID 0000-0002-1191-4954
Dean DerbyshireDivision of Chemistry Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden.
Eleonore von CastelmurDivision of Chemistry Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden.ORCID 0000-0001-7061-4890
Mikael LindgrenDepartment of Physics, Norwegian University of Science and Technology, 7491 Trondheim, Norway.ORCID 0000-0001-6649-7871
Per HammarströmDivision of Chemistry Department of Physics, Chemistry and Biology, Linköping University, 581 83 Linköping, Sweden.ORCID 0000-0001-5827-3587
Carolin KönigInstitute of Physical Chemistry and Electrochemistry, Leibniz University Hannover, Callinstr. 3A, 30167 Hannover, Germany.ORCID 0000-0001-8931-4337
Linköping University · SEKTH Royal Institute of Technology · SELeibniz University Hannover · DENorwegian University of Science and Technology · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Misfolding and aggregation of transthyretin (TTR) cause several amyloid diseases. Besides being an amyloidogenic protein, TTR has an affinity for bicyclic small-molecule ligands in its thyroxine (T4) binding site. One class of TTR ligands are trans-stilbenes. The trans-stilbene scaffold is also widely applied for amyloid fibril-specific ligands used as fluorescence probes and as positron emission tomography tracers for amyloid detection and diagnosis of amyloidosis. We have shown that native tetrameric TTR binds to amyloid ligands based on the trans-stilbene scaffold providing a platform for the determination of high-resolution structures of these important molecules bound to protein. In this study, we provide spectroscopic evidence of binding and X-ray crystallographic structure data on tetrameric TTR complex with the fluorescent salicylic acid-based pyrene amyloid ligand (Py1SA), an analogue of the Congo red analogue X-34. The ambiguous electron density from the X-ray diffraction, however, did not permit Py1SA placement with enough confidence likely due to partial ligand occupancy. Instead, the preferred orientation of the Py1SA ligand in the binding pocket was determined by molecular dynamics and umbrella sampling approaches. We find a distinct preference for the binding modes with the salicylic acid group pointing into the pocket and the pyrene moiety outward to the opening of the T4 binding site. Our work provides insight into TTR binding mode preference for trans-stilbene salicylic acid derivatives as well as a framework for determining structures of TTR-ligand complexes.

Indexed as

AmyloidosisStilbenesAmyloidAmyloidogenic ProteinsBinding SitesHumansLigandsMolecular Dynamics SimulationPrealbuminProtein BindingPyrenesSalicylic AcidAmyloidAmyloidogenic ProteinsLigandsPrealbuminPyrenesSalicylic AcidStilbenes

Identifiers

PMID37477604
PMCPMC10405211
OpenAlexW4384922258

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.